The cardiovascular drugs market is increasingly intersecting with sustainability goals, as pharma firms seek to reduce their environmental footprint while innovating. From eco-friendly drug delivery systems to biodegradable packaging, sustainability is no longer a side consideration but a core part of market strategy. This shift aligns with global calls for greener healthcare, where reducing...